Clinical Trials Browser

Phase 1/2 × Withdrawn × tucatinib × Clear all

NCT04896320 2023-06-22

2019-101826

Phase 1/2 Withdrawn

Breast Neoplasms, Neoplasm Metastasis

NCT04512261 2022-07-01

TOPAZ

Phase 1/2 Withdrawn

Brain Neoplasms, Breast Neoplasms, Central Nervous System Diseases